Search
Now showing items 11-14 of 14
Metabolomics of colistin methanesulfonate treated Mycobacterium tuberculosis
(Elsevier, 2018)
Over the past 5 years, there has been a renewed interest in finding new compounds with anti-TB action. Colistin methanesulfonate or polymyxin E, is a possible anti-TB drug candidate, which may in future be used either alone ...
Characterising the metabolic differences related to growth variation in farmed Haliotis midae
(Elsevier, 2018)
The South African abalone farming industry is entirely based on Haliotis midae, which has been commercially cultured with great success the last 20 years. Even though abalone are cultivated under identical farming conditions, ...
Metabolomic response to coffee consumption: application to a three‐stage clinical trial
(Wiley, 2018)
Background
Coffee is widely consumed and contains many bioactive compounds, any of which may impact pathways related to disease development.
Objective
To identify individual metabolite changes in response to ...
Elucidating the antimicrobial mechanisms of colistin sulfate on Mycobacterium tuberculosis using metabolomics
(Elsevier, 2018)
Considering the disadvantageous of first line anti-tuberculosis (TB) drugs, including poor patient adherence, drug side effects, the long treatment duration and rapidly increasing microbe resistance, alternative treatment ...